BriannaLNortonDO

Infectious Disease • New York, NY

Assistant Professor, Medicine, A Einstein Coll of Med of Yeshiva Univ

Join to view full profile

Dr. Norton is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Norton's full profile

Already have an account?

Office
353 E 17th St
Apt 16H
New York, NY 10003
Phone+1 917-848-2757

Education & Training

Duke University HospitalFellowship, Infectious Disease, 2009 - 2011
Icahn School of Medicine at Mount Sinai/Beth IsraelResidency, Internal Medicine, 2008 - 2009
NYIT College Of Osteopathic MedicineClass of 2005

Certifications & Licensure

NY State License 2008 - 2027
NC State License 2009 - 2013
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Infectious Disease

Publications & Presentations

PubMed

Variability of Hepatitis C Treatment Cascade Outcomes among People Who Inject Drugs across Geographically Diverse Clinics in the US: The HERO Study.
Snehal S Lopes, Moonseong Heo, Irene Pericot-Valverde, Brianna L Norton, Lynn E Taylor
Viruses. 2024-09-30
Effect of self-efficacy among persons who inject drugs treated with direct-acting antivirals on Hepatitis C treatment initiation, duration, completion, adherence, and ...
Snehal S Lopes, Irene Pericot-Valverde, J Edward Dotherow, Paula J Lum, Lynn E Taylor
Drug and Alcohol Dependence. 2024-09-01
Distrust in the Health Care System and Adherence to Direct-Acting Antiviral Therapy among People with HepatitisWho Inject Drugs.
Akhila Padi, Irene Pericot-Valverde, Moonseong Heo, James Edward Dotherow, Jiajing Niu
Viruses. 2024-08-16

Press Mentions

NIH Funds New Center to Treat Chronic Pain and Opioid Use Disorder at Einstein and MontefioreNovember 30th, 2021
Advocacy for Equity Around Evidence-Based Treatments: Overview and Proceedings of the AMERSA 2023 ConferenceFebruary 4th, 2024
New York State Intensifies Efforts to Eliminate Hepatitis C by 2030July 18th, 2024